Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Avidity Biosciences Inc.

    NASDAQ: RNA · Real-Time Price · USD
    29.84
    -1.53 (-4.88%)
    At close: Jun 16, 2025, 3:59 PM
    29.81
    -0.10%
    After-hours: Jun 16, 2025, 07:55 PM EDT

    Avidity Biosciences Statistics

    Share Statistics

    Avidity Biosciences has 120.54M shares outstanding. The number of shares has increased by 25.7% in one year.

    Shares Outstanding

    n/a
    		 120.54M

    Shares Change (YoY)

    n/a
    		 25.7%

    Shares Change (QoQ)

    n/a
    		 0.76%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 109.84M

    Failed to Deliver (FTD) Shares

    n/a
    		 86,425

    FTD / Avg. Volume

    n/a
    		 5.5%

    Short Selling Information

    The latest short interest is 16.17M, so 13.42% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 16.17M

    Short % of Shares Out

    n/a
    		 13.42%

    Short % of Float

    n/a
    		 13.55%

    Short Ratio (days to cover)

    n/a
    		 14.9

    Valuation Ratios

    The PE ratio is -10.07 and the forward PE ratio is -7.09. Avidity Biosciences's PEG ratio is 14.65.

    PE Ratio

    n/a
    		 -10.07

    Forward PE

    n/a
    		 -7.09

    PS Ratio

    n/a
    		 297.77

    Forward PS

    n/a
    		 3

    PB Ratio

    n/a
    		 2.28

    P/FCF Ratio

    n/a
    		 -10.54

    PEG Ratio

    n/a
    		 14.65
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Avidity Biosciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 15.73, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 15.73

    Quick Ratio

    n/a
    		 15.73

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.02

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $27,869.57

    Profits Per Employee

    n/a
    		 $-824,301.79

    Employee Count

    n/a
    		 391

    Asset Turnover

    n/a
    		 0.01

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -24.65% in the last 52 weeks. The beta is 0.95, so Avidity Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.95

    52-Week Price Change

    n/a
    		 -24.65%

    50-Day Moving Average

    n/a
    		 29.98

    200-Day Moving Average

    n/a
    		 35.54

    Relative Strength Index (RSI)

    n/a
    		 43.5

    Average Volume (20 Days)

    n/a
    		 1,572,638

    Income Statement

    In the last 12 months, Avidity Biosciences had revenue of 10.9M and earned -322.3M in profits. Earnings per share was -2.89.

    Revenue

    n/a
    		 10.9M

    Gross Profit

    n/a
    		 10.9M

    Operating Income

    n/a
    		 -378.94M

    Net Income

    n/a
    		 -322.3M

    EBITDA

    n/a
    		 -376.16M

    EBIT

    n/a
    		 -378.94M

    Earnings Per Share (EPS)

    n/a
    		 -2.89
    Full Income Statement

    Balance Sheet

    The company has 219.87M in cash and 6.8M in debt, giving a net cash position of 213.07M.

    Cash & Cash Equivalents

    n/a
    		 219.87M

    Total Debt

    n/a
    		 6.8M

    Net Cash

    n/a
    		 213.07M

    Retained Earnings

    n/a
    		 -893.07M

    Total Assets

    n/a
    		 1.46B

    Working Capital

    n/a
    		 1.35B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -300.87M and capital expenditures -7.07M, giving a free cash flow of -307.94M.

    Operating Cash Flow

    n/a
    		 -300.87M

    Capital Expenditures

    n/a
    		 -7.07M

    Free Cash Flow

    n/a
    		 -307.94M

    FCF Per Share

    n/a
    		 -2.76
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -3477.43% and -2957.71%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -3477.43%

    Pretax Margin

    n/a
    		 -2957.71%

    Profit Margin

    n/a
    		 -2957.71%

    EBITDA Margin

    n/a
    		 -3451.96%

    EBIT Margin

    n/a
    		 -3477.43%

    FCF Margin

    n/a
    		 -2825.88%

    Dividends & Yields

    RNA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for RNA is $67.5, which is 126.2% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $67.5

    Price Target Difference

    n/a
    		 126.2%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 14
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 16.36

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist